SCENAR

Jump to: navigation, search
RITM Scenar / Tomatex

Tomatex.gif

Formationca. 1980's
LocationTemplate:RF
WebsiteScenar Therapy

WikiDoc Resources for SCENAR

Articles

Most recent articles on SCENAR

Most cited articles on SCENAR

Review articles on SCENAR

Articles on SCENAR in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on SCENAR

Images of SCENAR

Photos of SCENAR

Podcasts & MP3s on SCENAR

Videos on SCENAR

Evidence Based Medicine

Cochrane Collaboration on SCENAR

Bandolier on SCENAR

TRIP on SCENAR

Clinical Trials

Ongoing Trials on SCENAR at Clinical Trials.gov

Trial results on SCENAR

Clinical Trials on SCENAR at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on SCENAR

NICE Guidance on SCENAR

NHS PRODIGY Guidance

FDA on SCENAR

CDC on SCENAR

Books

Books on SCENAR

News

SCENAR in the news

Be alerted to news on SCENAR

News trends on SCENAR

Commentary

Blogs on SCENAR

Definitions

Definitions of SCENAR

Patient Resources / Community

Patient resources on SCENAR

Discussion groups on SCENAR

Patient Handouts on SCENAR

Directions to Hospitals Treating SCENAR

Risk calculators and risk factors for SCENAR

Healthcare Provider Resources

Symptoms of SCENAR

Causes & Risk Factors for SCENAR

Diagnostic studies for SCENAR

Treatment of SCENAR

Continuing Medical Education (CME)

CME Programs on SCENAR

International

SCENAR en Espanol

SCENAR en Francais

Business

SCENAR in the Marketplace

Patents on SCENAR

Experimental / Informatics

List of terms related to SCENAR

The Scenar device, is the latest incarnation of an electronic instrument developed by scientists working in the Russian aerospace industry, in the town of Taganrog, Russia. The name is an acronym derived from "Self Controlled Energo-Neuro-adaptive Regulation". It has, in earlier incarnations been known as the "Inter-X -5002". Prof. Dr. Alexander M. Revenko (neurology) is the founder of the company. [1]

Description

Scenar.jpg

The device is sold for the treatment of acute and chronic pain, and is represented as being useful in solo therapy as well as in combination with other therapeutic modalities, as it "has very few contraindications" [1].

Scenar is represented as being capable of interaction with the nervous, immune and endocrine systems through a biofeedback mechanism. It is believed that it "ensures regulation of various mediators and neuropeptides". And, it main goal is the maintenance of homeostasis through interactions with the body's immune and hormonal systems[1].

History

In the beginning, there the SCENAR-035, or 'troika', as it is pronounced in Russian. The Grandmother of SCENARs. It was a good, reliable, stable, and effective model. Not very pretty on the outside, in a black rectangular case, yet nevertheless very functional. SCENAR-035 is known mostly just inside Russia, and some doctors work with it even now. In fact, those almost unbelievable SCENAR results reported by Dr. Yuri Gorfinkel and Dr Revenko in 1998 in his famous Summary of individual results (which appears all over the SCENAR literature) were obtained mostly with the SCENAR-035. This model was designed by Dr. Karasev and massively produced by OKB Ritm.

FDA Approvals

Scenar technology is, as of May, 2010, an FDA approved device, for treatment of pain, under the following class: DEVICE: SCENAR, MODEL 10, RITM OKB ZAO 510(k) NO: K092117(TRADITIONAL). It is cleared for the treatment and management of acute and chronic pain and the management of post-surgical and post-traumatic pain. It may be dispensed only upon the prescription of a licensed health care provider.[2]

Waveforms

Scenar waveforms 1a.jpg Scenar waveforms 1b.jpg Scenar waveforms 2.jpg

Scientific Research

Several studies have shown benefits in treatment of various conditions, most of which demonstrate results significantly greater than could be explained by placebo alone. Some studies the company provides were never published, but were performed at their request, however there are some rather interesting and positive results.

Enuresis

  • 1995 - V.A Lebedev (Physiotherapist), reported in the journal Вопросы курортологии, физиотерапии и лечебной физкультуры (Investigations in therapeutic spas, physiotherapy and therapeutic physical culture), that he "recommends a self-control energoneuroadaptive regulator (SCENAR) as effective in the treatment of neurogenic dysfunction of the bladder in children with nocturnal enuresis. This regulator operates according to the principles of Chinese medicine and may be used in sanatoria and at home by the children's parents specially trained by physiotherapist" [3].

Pain

  • 2004 - Lopatina, A.B, reported in a Dissertation for her Doctorate in Education, that the Scenar had shown benefits in "speeding the recovery period in athletes" [4].
  • 2005 - A study of 60 patients post trochanteric joint surgery, with the early model Scenar (InterX) device, run in Moscow, Russia and published in the Journal of Bone and Joint Surgery, Gorodetskiy et al, conclude that the scenar treated patients had significantly reduced pain as compared to the sham (placebo) or for the "non-invasive neuro-stimulation" groups. [5].
  • 2006 - Presenting at the XVth International Congress on Sports rehabilitation and Traumatology, P. Massetti gave a case study of two young men, 6 months post contusion; one 24 years old, with tears of the femoris and medial vastus lateralis, after 7 treatments showed significant reduction in pain, and increased range-of-motion, and after one week of treatment, the symptoms "were completely resolved" ; and the other 38 years old, with strain of the tibialis medius, interfering with his ability to participate in sports. His pain extended into the insertion of the Achilles tendon. His treatment was 2x week, together with CO2 laser and ultrasound. Following 10 applications of alternating laser+ultrasound and Scenar therapy the patient had a complete remission of symptoms [6].
  • 2006 - At the same Congress in which he gave his case report, Massetti published a paper in which he indicates having treated 20 patients, including both professional and amateur athletes with varying painful conditions. According to his report, all of the patients, after 2 treatments, 2x/week demonstrated "significant reduction in symptoms" unexplainable as resulting from any other possible cause. Massetti concludes that the Scenar "is an instrument capable of drastically reducing the time of recuperation in significant traumatic events" , [7]
  • 2008 - Writing about his experiences at the European Speed Skating championships (Germany) and the subsequent World's in Spain, Rosario Bella, (a Physiotherapist) for the FIHP (Roller Hockey), in a report published at the medical site FCE news, of Scenar use together with kinesiotaping, states, that the "results were appreciable in noting the time of recuperation and eduction of symptoms to a tolerable level in a good percentage of the cases treated, even during the competition". And, that the SCENAR taken together with the taping provided a synergistic effect, then when taken alone. [8]
  • 2010 - With results similar to their 2005 study, Gorodetskiy, et al, publishing in The Journal of Foot and Ankle Surgery in 2010, found results comparable to their earlier study, in patients post malleolar (ankle joint) fracture surgery [9].

Post-herpetic neuralgia

  • 2007 - M.R. Ing, publishing in the Hawaii Medical Journal, treated three consecutive patients with post-herpetic neuralgia and found that ALL resolved their pain in no more than 5 sessions over a three week period [10].

Duodenal ulcer

  • 2006 - In a study published in Клиническая Медицина (Clinical medicine), Tsimmerman, et al, reported that 103 cases of duodenal ulcer were treated with Scenar alone and together with standard therapy for H pylori. They determined that "led to positive changes in most of the parameters under study", and "Addition of SCENAR therapy to the complex conventional pharmacotherapy [sic] 'sped up' ulcer healing, increased the effectiveness of Helicobacter pylori eradication, and improved the condition of the gastroduodenal mucosa" [11].

See also

References

  1. 1.0 1.1 1.2 Scenar medical technology, Taganrog Russian Fed.: Scenar, Aug. 3, 2011, p. 6 |first1= missing |last1= in Authors list (help); Check date values in: |date= (help)
  2. "May 2010 510(k) Clearances". FDA website. FDA. Unknown parameter |Date= ignored (|date= suggested) (help)
  3. Lebedev, V.A. (July-Aug, 1995). "The treatment of neurogenic bladder dysfunction with enuresis in children using the SKENAR apparatus". Вопросы курортологии, физиотерапии и лечебной физкультуры (in Russian). Russia. 4: 25–26. Retrieved 4/8/2012. Check date values in: |accessdate=, |date= (help)
  4. Lopatina, Anna B. (2004), "Comparison of he effectiveness of SMC and SCENAR influence in Recovery of the Body Functions of Sportsmen after training", disserCat — электронная библиотека диссертаций (in Russian): 155pgs More than one of |work= and |journal= specified (help)
  5. Gorodetskiy, I.G. (Sept 2007). "Non Invasive interactive neurostimulation in the post-operative recovery of patients with a trochanteric fracture of the femur". The Journal of Bone and Joint Surgery. Journal of Bone and Joint Surgery. 89-B (11): 1488–1494. Unknown parameter |coauthors= ignored (help); Check date values in: |accessdate=, |date= (help); |access-date= requires |url= (help)
  6. Massetti, P. (2006). "Scenar: nuovo approccio diagnostico-terapeutico. Nostre esperienze in traumatologigia sportivo". Proc. of the XVth International Congress on Sports Rehabilitation and Traumatology (in Italian). IsoKinetic. The Rehabilitation of Winter and Mountain Sports Injuries. Check date values in: |accessdate= (help); |access-date= requires |url= (help)
  7. Massetti, P. (2006). "Nuroregolatore interattivo scenar: Nostre esperienze in traumatologigia sportivo e post chirugica". Proc. of the XVth International Congress on Sports Rehabilitation and Traumatology (in Italian). The Rehabilitation of Winter and Mountain Sports Injuries (7): 86–87. Check date values in: |accessdate= (help); |access-date= requires |url= (help)
  8. Bella, Rosario (2008). "Traumatologia nel pattinaggio a rotelle corsa: utilizzo dell'InterX e del taping kinesiologico nei piccoli traumi da sport". Report to FIHP medical commission, from European and World Championships (in Italian). fceonline.it. Retrieved 4/8/2012. Check date values in: |accessdate= (help)
  9. Gorodetskiy, I.G. (2010). "Use of non-invasive NeuroStimulation to improve Short-term recovery in Patients with Surgically repaired Ankle Fractures: A Prospective, Randomized Trial". The Journal of Foot and Ankle Surgery. Journal of Foot and Ankle Surgery. 49: 432–437. Unknown parameter |coauthors= ignored (help); Check date values in: |accessdate= (help); |access-date= requires |url= (help)
  10. Ing, M.R. (Sept,2007). "The use of electronic biofeedback for the management of post-herpetic neuralgia--a report of 3 cases". Hawaii Medical Journal. Honolulu, HI: Hawaii Medical Journal. 66 (9): 232–234. Retrieved 4/2012. Check date values in: |accessdate=, |date= (help)
  11. Tsimmerman, IaS (2006). "The effectiveness of SCENAR therapy in complex treatment of duodenal ulcer, and the mechanisms of its action". Клиническая Медицина (in Russian). Moscow, RF. 84 (7): 35–41. Retrieved 4/8/2012. Unknown parameter |coauthors= ignored (help); Check date values in: |accessdate= (help)

External links

Tomatex - Scenar Therapy


Linked-in.jpg